The Secret Strategy for Huge Gains in Biotech

The biotech industry is known for extreme innovation that can frequently lead to huge gains for early investors.
Take Pfizer Inc. (NYSE: PFE) for example. When the company released its groundbreaking cholesterol medicine Lipitor in 1996, the best-selling drug in the history of the pharmaceutical industry, shares proceeded to climb more than 300% in the following three years. Investors who knew Pfizer was on the cusp of a hot, new mega drug that made a lot of money in a very short amount of time.
Take a look at the incredible gains the stock saw...

But historically, finding the next hot thing in biotech and pharmaceuticals has been extremely difficult. Not only are there thousands of companies across the world pursuing thousands of new drugs and therapies, but most are subjected to strict regulatory standards that can delay or even prevent them from ever putting their drugs into the market.
But thanks to a new program the Food and Drug Administration (FDA) just implemented, finding hot new drugs with high probability of reaching commercialization just became a lot easier. (more)

Please bookmark us